This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 19-22, 2025
Manchester Grand Hyatt San DiegoSan Diego, CA

Thomas Vrucina
Deputy Head Liposome Technology at Polymun Scientific
Speaker

Profile

Thomas Vrucinais Deputy Head of Liposome Technology at Polymun Scientific GmbH. He possesses considerable expertise in the formulation of liposomes and LNPs, as well as in the development of the respective processes for their clinical application. He and the team at Polymun Scientific have significantly contributed to the 1st successful mRNA vaccine Comirnaty by optimizing and up-scaling the LNP process as well as by supporting clinical and early market supply of the successful Covid-19 vaccine.Thomas Vrucina studied at the FH Campus in Vienna, Austria, and earned his Bachelor and Master degrees in the field of Bioengineering as well as Biotechnological Quality Management